Panchsheel Organics Ltd. (BSE: 531726) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹140 Cr, it ranks #2,960 by market cap among the 6,197 Indian listed companies on FinBizNet, and #63 of 86 in Medicinal Chemicals and Botanical Products. At ₹106.75 (as of 16 Nov 2026), the share price is 30.9% below its 52-week high of ₹154.40 and 24.0% above its 52-week low of ₹86.10. The share price is down 22.7% over one year and down 12.2% over three months.
| Current Price | ₹106.75 |
|---|---|
| Market Cap | ₹140 Cr |
| BSE Code | 531726 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 12.9 |
| Return on Equity | 7.89% |
| Return on Assets | 4.54% |
| 52-Week Range | ₹86.10 – ₹154.40 |
| 1-Year Price Change | -22.7% |
| 3-Month Price Change | -12.2% |
| Beta (1Y) | 0.47 |
| Dividend Yield | 3.01% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.panchsheelorganics.com |
| Revenue | ₹25 Cr |
|---|---|
| Net Profit | ₹2 Cr |
| Net Margin | 9.4% |
| EPS (Basic) | ₹1.76 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Panchsheel Organics Ltd. reported revenue of ₹25 Cr in Q1 FY27, up 4.7% from ₹24 Cr in Q1 FY26 and down 20.6% from ₹31 Cr in Q4 FY26. It posted a net profit of ₹2 Cr for the quarter, against a net profit of ₹3 Cr in Q1 FY26 (down 18.9%). Across the 6 quarters from Q4 FY25 to Q1 FY27, quarterly revenue ranged from ₹24 Cr (Q1 FY26) to ₹31 Cr (Q4 FY26). The company was profitable in each of these 6 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q1 FY27 | ₹25 Cr | ₹2 Cr | 9.4% |
| Q4 FY26 | ₹31 Cr | ₹2 Cr | 5.5% |
| Q3 FY26 | ₹27 Cr | ₹4 Cr | 13.8% |
| Q2 FY26 | ₹25 Cr | ₹3 Cr | 10.3% |
| Q1 FY26 | ₹24 Cr | ₹3 Cr | 12.1% |
| Q4 FY25 | ₹28 Cr | ₹3 Cr | 11.2% |
Standalone figures (₹ crore, XBRL filings).
Delivery averaged 67.3% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Panchsheel Organics Limited engages in the manufacture and trading of bulk drugs and intermediates in India and internationally. It manufactures and exports active pharma ingredients (API), human and veterinary intermediates and finished formulations, specialty chemicals, hormones, steroids, etc. The company also offers a range of products in various categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis, erectile dysfunction, and others. Panchsheel Organics Limited was incorporated in 1989 and is based in Mumbai, India.
1. Bulk Drugs-This segment manufactures and trades in bulk drugs and intermediate products. 2. Formulation-This segment engages in manufacturing and trading of bulk drugs. 3. Manufacturing and Trading of Bulk Drug and Intermediate-This segment engages in marketing of formulation products in India.
1. Manufacturing and Trading of Bulk Drug and Intermediate-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,56,425 Cr | 39.5 | 14.72% | ₹16,199 Cr | +11.2% |
| Laurus Labs Ltd | ₹1,31,242 Cr | 145.6 | 17.74% | ₹2,206 Cr | +146.8% |
| Zydus Lifesciences Ltd | ₹1,19,651 Cr | 24.1 | 18.32% | ₹7,910 Cr | +26.0% |
| Dr.Reddys Lab | ₹1,15,464 Cr | 26.9 | 11.52% | ₹8,698 Cr | +14.5% |
| Cipla Limited | ₹1,14,712 Cr | 29.3 | 11.74% | ₹7,404 Cr | -7.6% |
| Mankind Pharma | ₹1,09,870 Cr | 57 | 12.45% | ₹4,338 Cr | +16.7% |
| Aurobindo Pharma Ltd. | ₹1,05,150 Cr | 30 | 9.93% | ₹10,263 Cr | +59.8% |
| Lupin Ltd | ₹92,087 Cr | 17.3 | 26.91% | ₹7,827 Cr | +0.4% |
| Panchsheel Organics Ltd. | ₹140 Cr | 12.9 | 7.89% | ₹25 Cr | -22.7% |
Listed by market capitalisation. Ratios are shown for context only.
Panchsheel Organics Ltd. is trading at ₹106.75, with a market capitalisation of ₹140 Cr.
Panchsheel Organics Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Panchsheel Organics Ltd. has a P/E of 12.9 and a return on equity of 7.89%.
Panchsheel Organics Ltd. is listed on the BSE under the scrip code 531726.
Panchsheel Organics Ltd.'s share price is down 22.7% over one year and down 12.2% over three months. Its 52-week range is ₹86.10 to ₹154.40.
In Q1 FY27, Panchsheel Organics Ltd. reported revenue of ₹25 Cr and net profit of ₹2 Cr, with basic EPS of ₹1.76 (standalone, parsed from the company's exchange filing).
Panchsheel Organics Ltd. reported revenue of ₹25 Cr in Q1 FY27, up 4.7% from ₹24 Cr in Q1 FY26 and down 20.6% from ₹31 Cr in Q4 FY26.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.